HHS funds vaccine candidates for Marburg, Sudan ebolavirus
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo. The last outbreaks of Marburg virus and Sudan ebolavirus were in Uganda, in 2017 and 2012, respectively. The Sabin Vaccine Institute will conduct nonclinical studies and complete manufacturing activities to advance the development of the vaccine candidates under a contract with HHS’s Biomedical Advanced Research and Development Authority. BARDA also is helping to develop and procure vaccines, therapeutics and diagnostics for the Ebola strain circulating in the Congo.
Related News Articles
Headline
The American Cancer Society released updated colorectal cancer screening guidelines May 27 that include the addition of a blood-based screening test to be…
Headline
The Centers for Disease Control and Prevention will host a webinar for clinicians May 28 at 2 p.m. ET on the ongoing Ebola outbreak in the Democratic…
Headline
The Centers for Disease Control and Prevention yesterday issued an advisory on the Ebola disease outbreak in the Democratic Republic of the Congo and Uganda.…
Headline
The World Health Organization May 17 declared a public health emergency of international concern due to an Ebola outbreak. The WHO said that as of May 16,…
Headline
The Centers for Disease Control and Prevention released a Health Alert Network Health Advisory May 8 notifying clinicians and health departments of the…
Headline
The Centers for Medicare & Medicaid Services April 13 announced that more than 150 organizations have been accepted to participate in the launch of its…